Cargando…
Dual Anticoagulation With Warfarin and Apixaban: A Case Report
We report the case of a female with recurrent venous thromboembolisms (VTEs) despite being appropriately anticoagulated. Different anticoagulants were trialed and all led to treatment failure. As a result, the patient was started on dual anticoagulation with warfarin and apixaban. There were no recu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556604/ https://www.ncbi.nlm.nih.gov/pubmed/36249603 http://dx.doi.org/10.7759/cureus.29093 |
_version_ | 1784807099510816768 |
---|---|
author | Parker, Kristen Yonosko, Paula Pilkington, Deon |
author_facet | Parker, Kristen Yonosko, Paula Pilkington, Deon |
author_sort | Parker, Kristen |
collection | PubMed |
description | We report the case of a female with recurrent venous thromboembolisms (VTEs) despite being appropriately anticoagulated. Different anticoagulants were trialed and all led to treatment failure. As a result, the patient was started on dual anticoagulation with warfarin and apixaban. There were no recurrences of clots while the patient was adherent to dual anticoagulation. This case report adds to current literature demonstrating the efficacy of dual anticoagulation in patients with recurrent VTE who fail single-agent therapy. It also demonstrates the need for additional studies that evaluate the utility of dual anticoagulants as a treatment modality for patients failing monotherapy. |
format | Online Article Text |
id | pubmed-9556604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-95566042022-10-15 Dual Anticoagulation With Warfarin and Apixaban: A Case Report Parker, Kristen Yonosko, Paula Pilkington, Deon Cureus Hematology We report the case of a female with recurrent venous thromboembolisms (VTEs) despite being appropriately anticoagulated. Different anticoagulants were trialed and all led to treatment failure. As a result, the patient was started on dual anticoagulation with warfarin and apixaban. There were no recurrences of clots while the patient was adherent to dual anticoagulation. This case report adds to current literature demonstrating the efficacy of dual anticoagulation in patients with recurrent VTE who fail single-agent therapy. It also demonstrates the need for additional studies that evaluate the utility of dual anticoagulants as a treatment modality for patients failing monotherapy. Cureus 2022-09-12 /pmc/articles/PMC9556604/ /pubmed/36249603 http://dx.doi.org/10.7759/cureus.29093 Text en Copyright © 2022, Parker et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Hematology Parker, Kristen Yonosko, Paula Pilkington, Deon Dual Anticoagulation With Warfarin and Apixaban: A Case Report |
title | Dual Anticoagulation With Warfarin and Apixaban: A Case Report |
title_full | Dual Anticoagulation With Warfarin and Apixaban: A Case Report |
title_fullStr | Dual Anticoagulation With Warfarin and Apixaban: A Case Report |
title_full_unstemmed | Dual Anticoagulation With Warfarin and Apixaban: A Case Report |
title_short | Dual Anticoagulation With Warfarin and Apixaban: A Case Report |
title_sort | dual anticoagulation with warfarin and apixaban: a case report |
topic | Hematology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556604/ https://www.ncbi.nlm.nih.gov/pubmed/36249603 http://dx.doi.org/10.7759/cureus.29093 |
work_keys_str_mv | AT parkerkristen dualanticoagulationwithwarfarinandapixabanacasereport AT yonoskopaula dualanticoagulationwithwarfarinandapixabanacasereport AT pilkingtondeon dualanticoagulationwithwarfarinandapixabanacasereport |